Predictive Presymptomatic Testing Market
PUBLISHED: 2025 ID: SMRC28531
SHARE
SHARE

Predictive Presymptomatic Testing Market

Predictive Presymptomatic Testing Market Forecasts to 2030 - Global Analysis By Type (Genetic Testing, Biochemical Testing, Molecular Testing and Other Types), Indication, Technology, Sample, End User and By Geography

4.9 (21 reviews)
4.9 (21 reviews)
Published: 2025 ID: SMRC28531

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Predictive Presymptomatic Testing Market is accounted for $5.6 billion in 2024 and is expected to reach $10.9 billion by 2030 growing at a CAGR of 11.6% during the forecast period. Predictive presymptomatic testing is a genetic method used to identify individuals at risk of developing a specific hereditary condition before symptoms appear. It analyzes DNA to detect mutations or markers associated with certain diseases, such as Huntington's disease, certain cancers, and cardiovascular or neurodegenerative disorders. This testing estimates the likelihood of developing a condition in the future; enabling proactive measures like lifestyle changes and increased surveillance. 

According to the article published by Frontiers in 2021, in Japan, the rare hereditary disease prevalence was equivalent to less than 1 in 2,500 people.

Market Dynamics: 

Driver: 

Increasing awareness and incidence of hereditary diseases

As more individuals become aware of their genetic predispositions, there is a growing demand for early testing to enable timely interventions. The increasing prevalence of hereditary conditions such as cancer, cardiovascular diseases, and neurological disorders has further amplified the need for predictive testing. Government initiatives and public health campaigns aimed at promoting genetic literacy also contribute to market growth. Additionally, the growing acceptance of preventive healthcare practices is driving the adoption of predictive presymptomatic testing worldwide.

Restraint:

Ethical and psychological concerns

Many individuals fear the potential psychological burden of knowing their genetic risks, which can lead to anxiety and stress. Ethical dilemmas, including the potential misuse of genetic information by insurers or employers, also pose challenges to market growth. Moreover, concerns about the accuracy of test results and the implications of false positives or negatives add to the hesitancy. Cultural and societal stigma around hereditary diseases further restricts the widespread adoption of these tests hampering the growth of the market.

Opportunity:

Advancements in genetic testing technologies

Innovations such as next-generation sequencing (NGS) and CRISPR-based techniques have enhanced the accuracy, speed, and affordability of genetic testing. These technologies enable comprehensive analysis of genetic variants associated with hereditary diseases, allowing for personalized risk assessment. The integration of artificial intelligence (AI) and big data analytics further supports predictive modeling and enhances the clinical utility of testing. The development of direct-to-consumer genetic testing kits also widens access, creating new avenues for market growth. 

Threat:

Accuracy and reliability concerns

Variability in test results due to differences in testing methodologies and laboratory standards undermines consumer trust. False positives or negatives can lead to inappropriate medical decisions, further impacting patient outcomes. The lack of universal regulatory frameworks for genetic testing exacerbates these challenges, creating disparities in test quality across regions. Additionally, the complexity of interpreting genetic data requires specialized expertise, which may not always be available. These factors collectively threaten the market’s growth potential and underscore the need for robust quality assurance measures.

Covid-19 Impact

The Covid-19 pandemic significantly influenced the predictive presymptomatic testing market. On one hand, disruptions in healthcare systems and diagnostic services delayed testing procedures and reduced patient access to routine screenings. On the other hand, the pandemic underscored the importance of preventive healthcare, spurring interest in genetic testing for early disease detection. As the world transitions to a post-pandemic phase, the market is poised for recovery and growth, driven by renewed focus on preventive health measures.

The genetic testing segment is expected to be the largest during the forecast period

The genetic testing segment is expected to account for the largest market share during the forecast period owing to early diagnosis and intervention for hereditary diseases. Technological advancements and growing awareness about genetic risks have spurred the adoption of these tests. Furthermore, the availability of non-invasive testing methods, like saliva-based genetic testing, has made predictive presymptomatic tests more accessible and affordable. 

The next-generation sequencing (NGS) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the next-generation sequencing (NGS) segment is predicted to witness the highest growth rate due to rapid evolution of genomic medicine and the rise in hereditary disease incidence are factors contributing to this trend. This segment encompasses tests for a variety of conditions, including cancers, cardiovascular diseases, and neurological disorders, all of which benefit from early identification and intervention. The increasing availability of affordable genetic testing options is also expected to drive substantial growth in this segment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to well-established healthcare infrastructure, and there is a high demand for genetic testing due to increasing awareness and a growing number of individuals seeking personalized healthcare. Furthermore, the presence of leading research institutions and biotech companies specializing in genetic testing technologies contributes to North America's dominant market share. Government policies promoting genetic literacy and personalized healthcare are also expected to play a significant role in North America's continued market leadership.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by advancements in healthcare infrastructure, rising disposable incomes, and an increasing focus on preventive healthcare. Additionally, countries like China and India are experiencing significant growth in genetic research and testing capabilities, driven by both government investments and private sector initiatives. As awareness around hereditary diseases and genetic testing increases, demand for predictive presymptomatic tests is likely to surge in this region, particularly in urban centers with access to cutting-edge healthcare services.

Key players in the market

Some of the key players in Predictive Presymptomatic Testing market include 23andMe, Abbott Laboratories Inc, Quest Diagnostics Inc, Positive Bioscience, Color Genomics, Gene by Gene, Mapmygenome, Myriad Genetics, BioAxis DNA Research Center Private Limited, Direct Laboratory Services LLC, Pathway Genomics Corporation, Ambry Genetics Corporation, Akonni Biosystems, Element Biosciences, Eurofins Scientific and NGeneBio.

Key Developments:

In January 2024, 23andMe Holding Co. announced the launch of Discover23®, a new research offering enabling authorized collaborators to securely access the power and diversity of the 23andMe research cohort through a Trusted Research Environment (TRE) developed by Lifebit.

In December 2024, Abbott announced it has reached an agreement with DexCom, Inc. to settle all outstanding patent disputes between the companies in cases related to continuous glucose monitoring products.

In December 2024, Quest Diagnostics launched health coaching on questhealth.com to help individuals take control of their health. The holistic programs focus on several key areas, including general health, weight management, chronic kidney disease, type 2 diabetes, or high cholesterol.

Types Covered:
• Genetic Testing
• Biochemical Testing
• Molecular Testing
• Other Types 

Indications Covered:
• Oncology 
• Neurological Disorders 
• Cardiovascular Disorders 
• Endocrine Disorders 
• Inherited Conditions 
• Other Indications    

Technologies Covered:
• Next-Generation Sequencing (NGS) 
• Polymerase Chain Reaction (PCR) 
• Microarray Technology 
• Fluorescent In Situ Hybridization (FISH) 
• Other Technologies  

Samples Covered:
• Blood
• Saliva
• Tissue Biopsy
• Other Samples 

End Users Covered:
• Hospitals 
• Diagnostic Laboratories 
• Research & Academic Institutions 
• Specialty Clinics 
• Other End Users 

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary        
          
2 Preface         
 2.1 Abstract        
 2.2 Stake Holders       
 2.3 Research Scope       
 2.4 Research Methodology      
  2.4.1 Data Mining      
  2.4.2 Data Analysis      
  2.4.3 Data Validation      
  2.4.4 Research Approach      
 2.5 Research Sources       
  2.5.1 Primary Research Sources     
  2.5.2 Secondary Research Sources     
  2.5.3 Assumptions      
          
3 Market Trend Analysis       
 3.1 Introduction       
 3.2 Drivers        
 3.3 Restraints       
 3.4 Opportunities       
 3.5 Threats        
 3.6 Technology Analysis      
 3.7 End User Analysis       
 3.8 Emerging Markets       
 3.9 Impact of Covid-19       
          
4 Porters Five Force Analysis       
 4.1 Bargaining power of suppliers      
 4.2 Bargaining power of buyers      
 4.3 Threat of substitutes      
 4.4 Threat of new entrants      
 4.5 Competitive rivalry       
          
5 Global Predictive Presymptomatic Testing Market, By Type    
 5.1 Introduction       
 5.2 Genetic Testing       
  5.2.1 Single-Gene Testing     
  5.2.2 Whole Genome Sequencing     
  5.2.3 Whole Exome Sequencing     
 5.3 Biochemical Testing       
 5.4 Molecular Testing       
 5.5 Other Types       
          
6 Global Predictive Presymptomatic Testing Market, By Indication   
 6.1 Introduction       
 6.2 Oncology        
 6.3 Neurological Disorders      
 6.4 Cardiovascular Disorders      
 6.5 Endocrine Disorders      
 6.6 Inherited Conditions      
 6.7 Other Indications       
          
7 Global Predictive Presymptomatic Testing Market, By Technology   
 7.1 Introduction       
 7.2 Next-Generation Sequencing (NGS)     
 7.3 Polymerase Chain Reaction (PCR)     
 7.4 Microarray Technology      
 7.5 Fluorescent In Situ Hybridization (FISH)     
 7.6 Other Technologies       
          
8 Global Predictive Presymptomatic Testing Market, By Sample    
 8.1 Introduction       
 8.2 Blood        
 8.3 Saliva        
 8.4 Tissue Biopsy       
 8.5 Other Samples       
          
9 Global Predictive Presymptomatic Testing Market, By End User   
 9.1 Introduction       
 9.2 Hospitals        
 9.3 Diagnostic Laboratories      
 9.4 Research & Academic Institutions     
 9.5 Specialty Clinics       
 9.6 Other End Users       
          
10 Global Predictive Presymptomatic Testing Market, By Geography   
 10.1 Introduction       
 10.2 North America       
  10.2.1 US       
  10.2.2 Canada       
  10.2.3 Mexico        
 10.3 Europe        
  10.3.1 Germany       
  10.3.2 UK       
  10.3.3 Italy       
  10.3.4 France       
  10.3.5 Spain       
  10.3.6 Rest of Europe      
 10.4 Asia Pacific       
  10.4.1 Japan       
  10.4.2 China       
  10.4.3 India       
  10.4.4 Australia       
  10.4.5 New Zealand      
  10.4.6 South Korea      
  10.4.7 Rest of Asia Pacific      
 10.5 South America       
  10.5.1 Argentina      
  10.5.2 Brazil       
  10.5.3 Chile       
  10.5.4 Rest of South America     
 10.6 Middle East & Africa      
  10.6.1 Saudi Arabia      
  10.6.2 UAE       
  10.6.3 Qatar       
  10.6.4 South Africa      
  10.6.5 Rest of Middle East & Africa     
          
11 Key Developments        
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures   
 11.2 Acquisitions & Mergers      
 11.3 New Product Launch      
 11.4 Expansions       
 11.5 Other Key Strategies      
          
12 Company Profiling        
 12.1 23andMe        
 12.2 Abbott Laboratories Inc.      
 12.3 Quest Diagnostics Inc.      
 12.4 Positive Bioscience       
 12.5 Color Genomics       
 12.6 Gene by Gene       
 12.7 Mapmygenome       
 12.8 Myriad Genetics       
 12.9 BioAxis DNA Research Center Private Limited    
 12.10 Direct Laboratory Services LLC      
 12.11 Pathway Genomics Corporation     
 12.12 Ambry Genetics Corporation      
 12.13 Akonni Biosystems       
 12.14 Element Biosciences      
 12.15 Eurofins Scientific       
 12.16 NGeneBio       
          
List of Tables         
1 Global Predictive Presymptomatic Testing Market Outlook, By Region (2022-2030) ($MN) 
2 Global Predictive Presymptomatic Testing Market Outlook, By Type (2022-2030) ($MN) 
3 Global Predictive Presymptomatic Testing Market Outlook, By Genetic Testing (2022-2030) ($MN)
4 Global Predictive Presymptomatic Testing Market Outlook, By Single-Gene Testing (2022-2030) ($MN)
5 Global Predictive Presymptomatic Testing Market Outlook, By Whole Genome Sequencing (2022-2030) ($MN)
6 Global Predictive Presymptomatic Testing Market Outlook, By Whole Exome Sequencing (2022-2030) ($MN)
7 Global Predictive Presymptomatic Testing Market Outlook, By Biochemical Testing (2022-2030) ($MN)
8 Global Predictive Presymptomatic Testing Market Outlook, By Molecular Testing (2022-2030) ($MN)
9 Global Predictive Presymptomatic Testing Market Outlook, By Other Types (2022-2030) ($MN)
10 Global Predictive Presymptomatic Testing Market Outlook, By Indication (2022-2030) ($MN) 
11 Global Predictive Presymptomatic Testing Market Outlook, By Oncology (2022-2030) ($MN) 
12 Global Predictive Presymptomatic Testing Market Outlook, By Neurological Disorders (2022-2030) ($MN)
13 Global Predictive Presymptomatic Testing Market Outlook, By Cardiovascular Disorders (2022-2030) ($MN)
14 Global Predictive Presymptomatic Testing Market Outlook, By Endocrine Disorders (2022-2030) ($MN)
15 Global Predictive Presymptomatic Testing Market Outlook, By Inherited Conditions (2022-2030) ($MN)
16 Global Predictive Presymptomatic Testing Market Outlook, By Other Indications (2022-2030) ($MN)
17 Global Predictive Presymptomatic Testing Market Outlook, By Technology (2022-2030) ($MN) 
18 Global Predictive Presymptomatic Testing Market Outlook, By Next-Generation Sequencing (NGS) (2022-2030) ($MN)
19 Global Predictive Presymptomatic Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2022-2030) ($MN)
20 Global Predictive Presymptomatic Testing Market Outlook, By Microarray Technology (2022-2030) ($MN)
21 Global Predictive Presymptomatic Testing Market Outlook, By Fluorescent In Situ Hybridization (FISH) (2022-2030) ($MN)
22 Global Predictive Presymptomatic Testing Market Outlook, By Other Technologies (2022-2030) ($MN)
23 Global Predictive Presymptomatic Testing Market Outlook, By Sample (2022-2030) ($MN) 
24 Global Predictive Presymptomatic Testing Market Outlook, By Blood (2022-2030) ($MN) 
25 Global Predictive Presymptomatic Testing Market Outlook, By Saliva (2022-2030) ($MN) 
26 Global Predictive Presymptomatic Testing Market Outlook, By Tissue Biopsy (2022-2030) ($MN)
27 Global Predictive Presymptomatic Testing Market Outlook, By Other Samples (2022-2030) ($MN)
28 Global Predictive Presymptomatic Testing Market Outlook, By End User (2022-2030) ($MN) 
29 Global Predictive Presymptomatic Testing Market Outlook, By Hospitals (2022-2030) ($MN) 
30 Global Predictive Presymptomatic Testing Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
31 Global Predictive Presymptomatic Testing Market Outlook, By Research & Academic Institutions (2022-2030) ($MN)
32 Global Predictive Presymptomatic Testing Market Outlook, By Specialty Clinics (2022-2030) ($MN)
33 Global Predictive Presymptomatic Testing Market Outlook, By Other End Users (2022-2030) ($MN)
          
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials